MURA
Mural Oncology plc

808
Loading...
Loading...
Mural Oncology Plc is a clinical-stage oncology company, which focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
116

Frequently Asked Questions

What is Market Cap of Mural Oncology plc?
What is the 52-week high for Mural Oncology plc?
What is the 52-week low for Mural Oncology plc?
What is Mural Oncology plc stock price today?
What was Mural Oncology plc stock price yesterday?
What is the PE ratio of Mural Oncology plc?
What is the Price-to-Book ratio of Mural Oncology plc?
What is the 50-day moving average of Mural Oncology plc?
How many employess does Mural Oncology plc has?

Latest MURA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.